| For: | Zhou X, Wang DY, Ding CY, Liu H, Sun ZQ. Psychosocial adaptation and influencing factors among patients with chemotherapy-induced peripheral neuropathy. World J Clin Cases 2022; 10(15): 4843-4855 [PMID: 35801039 DOI: 10.12998/wjcc.v10.i15.4843] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i15/4843.htm |
| Number | Citing Articles |
| 1 |
Fangyi Li, Linyu Zhou, Biao He, Xiaoli Huang, Chunmei Liu, Qing Li, Qiumei Ma, Tian Xiao, Ruihan Xiao, Ao Tang, Xueqin Qiu, Xiaoju Chen. Trajectories and predictors of benefit finding among patients with colorectal cancer undergoing chemotherapy: A longitudinal observational study. Asia-Pacific Journal of Oncology Nursing 2025; 12: 100805 doi: 10.1016/j.apjon.2025.100805
|
| 2 |
Eun Young Kim, Se Jin Hong. Real-Life Experiences of Chemotherapy-Induced Peripheral Neuropathy in Patients with Cancer: A Qualitative Meta-Synthesis Study. Seminars in Oncology Nursing 2023; 39(5): 151499 doi: 10.1016/j.soncn.2023.151499
|
| 3 |
Ya-Jung Wang, Ming-Chia Hung, Chih-Jung Wu, Chuan-Chuan Huang, Han-Wen Cao. Effects of an exercise program on chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer individuals receiving taxanes: a randomized controlled trial. Supportive Care in Cancer 2025; 33(12) doi: 10.1007/s00520-025-10121-8
|
| 4 |
Silvia Belloni, Arianna Magon, Chiara Giacon, Francesca Savioni, Gianluca Conte, Rosario Caruso, Cristina Arrigoni. Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties. Current Oncology 2024; 31(12): 7828 doi: 10.3390/curroncol31120577
|
| 5 |
Ding Yang, Xianyan Zhan, Yajuan Fan, Yuan Gao, Qingyan Ma, Xiancang Ma, Min Jia. Gender-specific associations of blood immune markers with symptoms and cognitive function in major depressive disorder: a cross-sectional observational study. BMC Psychiatry 2025; 25(1) doi: 10.1186/s12888-025-07277-2
|
| 6 |
Yu Xiaoqian, Ji Hongmei, Zhou Lizhi, Hao Xijun. Examining the effectiveness of combination therapy in alleviating peripheral neuropathy and sleep disorders in breast cancer patients receiving chemotherapy. Supportive Care in Cancer 2025; 33(11) doi: 10.1007/s00520-025-09987-5
|
